HemaSphere (Jan 2025)
High levels of global hydroxymethylation predict worse overall survival in MDS patients treated with azacitidine
- Francesca Tiso,
- Florentien E. M. in 't Hout,
- Ruth Knops,
- Leonie I. Kroeze,
- Arno vanRooij,
- Arjan A. van deLoosdrecht,
- Theresia M. Westers,
- Saskia M. C. Langemeijer,
- Claude Preudhomme,
- Nicolas Duployez,
- Pierre Fenaux,
- Olivier Kosmider,
- Didier Bouscary,
- Aniek O. deGraaf,
- Joost H. A. Martens,
- Bert A. van derReijden,
- Lionel Adès,
- Michaela Fontenay,
- Joop H. Jansen
Affiliations
- Francesca Tiso
- Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands
- Florentien E. M. in 't Hout
- Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands
- Ruth Knops
- Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands
- Leonie I. Kroeze
- Department of Pathology Radboud University Medical Center Nijmegen The Netherlands
- Arno vanRooij
- Department of Laboratory Medicine, Laboratory for Genetic, Endocrine, and Metabolic Diseases Radboud University Medical Center Nijmegen The Netherlands
- Arjan A. van deLoosdrecht
- Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands
- Theresia M. Westers
- Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam The Netherlands
- Saskia M. C. Langemeijer
- Department of Hematology Radboud University Medical Center Nijmegen The Netherlands
- Claude Preudhomme
- Department Hematology Lille University Hospital Lille and INSERM UMR‐S 1277 Lille France
- Nicolas Duployez
- Department Hematology Lille University Hospital Lille and INSERM UMR‐S 1277 Lille France
- Pierre Fenaux
- Department Hematology Hôpital Saint Louis, Assistance publique hôpitaux de paris, and Université de Paris Cité Paris France
- Olivier Kosmider
- Division INSERM U1016, Assistance Publique‐Hôpitaux de Paris, Cochin Hospital and Université Paris Cité, CNRS, INSERM Cochin Institute Paris France
- Didier Bouscary
- Division INSERM U1016, Assistance Publique‐Hôpitaux de Paris, Cochin Hospital and Université Paris Cité, CNRS, INSERM Cochin Institute Paris France
- Aniek O. deGraaf
- Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands
- Joost H. A. Martens
- Department of Molecular Biology Radboud University Nijmegen The Netherlands
- Bert A. van derReijden
- Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands
- Lionel Adès
- Department Hematology Hôpital Saint Louis, Assistance publique hôpitaux de paris, and Université de Paris Cité Paris France
- Michaela Fontenay
- Division INSERM U1016, Assistance Publique‐Hôpitaux de Paris, Cochin Hospital and Université Paris Cité, CNRS, INSERM Cochin Institute Paris France
- Joop H. Jansen
- Department of Laboratory Medicine, Laboratory of Hematology Radboud University Medical Center and Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands
- DOI
- https://doi.org/10.1002/hem3.70034
- Journal volume & issue
-
Vol. 9,
no. 1
pp. n/a – n/a
Abstract
No abstracts available.
